PROGRAM AT A GLANCE
Explore our full program and plan your schedule! Browse sessions by organization or day — or download the event app to make the most of your experience.
| Nom de session | Talk Title | Nom de la localisation | Date | Temps | |
|---|---|---|---|---|---|
| MASLD/MASH – management and future of therapeutics | MASLD/MASH – management and future of therapeutics | Giada Sebastiani | 308A | samedi 1 mars 2025 | 08:30 - 09:15 |
| Nurse-led Models of Care in Hepatology | Nurse-led hepatology program | Hayley McPhail and Carmen Cabral | 308A | samedi 1 mars 2025 | 10:00 - 10:30 |
| Nurse-led Models of Care in Hepatology | Nurse-led program in North Bay | Saskia Hildebrandt, Keri McGuire-Trahan, and Kaitlyn Barber | 308A | samedi 1 mars 2025 | 10:30 - 11:00 |
| Navigating Liver Health During and After Pregnancy | HCV and post-pregnancy | Chelsea Elwood | 308A | samedi 1 mars 2025 | 11:15 - 11:45 |
| Navigating Liver Health During and After Pregnancy | Pregnancy and liver disease | Hin Hin Ko | 308A | samedi 1 mars 2025 | 11:45 - 12:15 |
| Nom de session | Talk Title | Nom de la localisation | Date | Temps | |
|---|---|---|---|---|---|
| Opening | Registration, breakfast - Inscription, petit déjeuner | Edith Picard | 306A | vendredi 28 février 2025 | 07:30 - 08:00 |
| Opening | Elder’s blessing, Welcome and Introductions | Marie-Louise Vachon and Guillaume Fontaine | 306A | vendredi 28 février 2025 | 08:00 - 08:15 |
| Biomedical Research | Challenges in HCV vaccine design - can our models give us insights? | Thomas Pietschmann | 306A | vendredi 28 février 2025 | 08:15 - 08:45 |
| Biomedical Research | Molecular mechanisms of development of T-cell exhaustion during chronic viral infection in the context of HCV | Mohamed Abdel Hakeem | 306A | vendredi 28 février 2025 | 08:45 - 09:15 |
| Biomedical Research | Oral Presentations: Investigating the role of protein kinase r in the antiviral activity of cyclosporine a against HCV | Carla Gallardo | 306A | vendredi 28 février 2025 | 09:15 - 09:30 |
| Biomedical Research | Oral Presentations: HCV-specific CD4+ T-cells are targeted by HIV-1 infection and viral reservoir persistence during antiretroviral therapy | Samaa T. Gobran | 306A | vendredi 28 février 2025 | 09:30 - 09:45 |
| Coffee Break - Pause café and poster viewing | 306A | vendredi 28 février 2025 | 09:45 - 10:05 | ||
| Clinical Research | Developing and implementing strategies for HCV point-of-care testing adoption in the United States | Guillaume Fontaine | 306A | vendredi 28 février 2025 | 10:05 - 10:35 |
| Clinical Research | Linkage to HCV care for pregnant and postpartum women | Mia Biondi | 306A | vendredi 28 février 2025 | 10:35 - 11:05 |
| Clinical Research | Oral Presentations: Real-world implementation of point-of-care (POC) HCV RNA testing in a mobile unit in homeless encampments and shelters in Ontario, Canada: Impact on the Cascade of Care | Lindsay Myles | 306A | vendredi 28 février 2025 | 11:05 - 11:20 |
| Clinical Research | Oral Presentations: Hepatitis C self-testing among people with experience in Canadian corrections | Tamara Barnett | 306A | vendredi 28 février 2025 | 11:20 - 11:35 |
| Poster Session – Présentation des Affiches : CanHepC evaluation of posters | 306A | vendredi 28 février 2025 | 12:30 - 13:00 | ||
| Panel | Addressing Disparities Impacting Women: Prioritizing Gender-Responsive Strategies in the Hepatitis C Response | Madison Kennedy, Mia Biondi, Valérie Martel-Lafferière, Lucie-Catherine Ouimet, Danielle Willier, Michella Seymour, Victoria Thomas | 306A | vendredi 28 février 2025 | 13:00 - 13:55 |
| Population Health and Health Services Research | Evaluating varying strategies to address disparities in HCV care access and uptake | Seun O Falade-Nwulia | 306A | vendredi 28 février 2025 | 13:55 - 14:25 |
| Population Health and Health Services Research | Strengthening evidence-support systems to inform policy decision-making | Mike Wilson | 306A | vendredi 28 février 2025 | 14:25 - 14:45 |
| Coffee Break - Pause café and poster browsing | 306A | vendredi 28 février 2025 | 14:45 - 15:05 | ||
| Population Health and Health Services Research | Sex and gender differences in HCV risk, prevention and cascade of care | Sarah Larney | 306A | vendredi 28 février 2025 | 15:05 - 15:35 |
| Population Health and Health Services Research | Oral Presentation: Barriers and facilitators to improving uptake of the prison needle exchange program in Canadian federal prisons: Lessons learned using nominal group technique | Andrew B. Mendolwitz | 306A | vendredi 28 février 2025 | 15:35 - 15:50 |
| Population Health and Health Services Research | Oral Presentation: Disparities in hepatocellular carcinoma screening and in its detection rates in individuals with Hepatitis C or C and cirrhosis in Canada | Gisela MacPhail | 306A | vendredi 28 février 2025 | 15:50 - 16:05 |
| Population Health and Health Services Research | Oral Presentation: Evaluation of Hepatitis C Virus testing and care for infants born to individuals positive before or during pregnancy in Ontario, Canada: A Population-based retrospective analysis | Jean Damascene Makuza | 306A | vendredi 28 février 2025 | 16:05 - 16:20 |
| Population Health and Health Services Research | Oral Presentation: Simple but Not Easy: Scaffolding the HCV Cascade of Care | Nadine Kronfli | 306A | vendredi 28 février 2025 | 16:20 - 16:35 |
| Closing | CanHepC Trainee Awards Ceremony | Nadine Kronfli | 306A | vendredi 28 février 2025 | 16:35 - 16:45 |
| Closing Remarks - Mot de la fin | Marie-Louise Vachon and Guillaume Fontaine | 306A | vendredi 28 février 2025 | 16:45 - 16:55 |
| Nom de session | Talk Title | Nom de la localisation | Date | Temps | |
|---|---|---|---|---|---|
| Opening | Opening Remarks | Giada Sebastiani | 307AB | vendredi 28 février 2025 | 08:30 - 08:40 |
| Epidemiology and Natural History | Epidemiology and knowledge gaps in Canada: where do we stand? | Sahar Saeed | 307AB | vendredi 28 février 2025 | 08:40 - 09:00 |
| Epidemiology and Natural History | The relationship among obesity, diabetes and adipose tissue: implication for MASLD | Andre Tchernof | 307AB | vendredi 28 février 2025 | 09:00 - 09:20 |
| Epidemiology and Natural History | Don’t forget the heart! Cardiovascular implications in MASLD | Paolo Raggi | 307AB | vendredi 28 février 2025 | 09:20 - 09:40 |
| Epidemiology and Natural History | Oral Presentation: Characteristics and burden of illness of persons with metabolic dysfunction-associated steatotic liver disease (MASLD) in Ontario, Canada: an observational study | Keyur Patel | 307AB | vendredi 28 février 2025 | 09:40 - 10:10 |
| Diagnostics | Non-invasive tests for risk stratification | Keyur Patel | 307AB | vendredi 28 février 2025 | 10:30 - 10:50 |
| Diagnostics | Diagnostics | Magnus McLeod & Felice Cinque | 307AB | vendredi 28 février 2025 | 10:30 - 12:00 |
| Diagnostics | Imaging assessment of MASLD and artificial intelligence applications | Jérémy Dana | 307AB | vendredi 28 février 2025 | 10:50 - 11:10 |
| Diagnostics | Models of care for MASLD | Abdel Aziz Shaheen | 307AB | vendredi 28 février 2025 | 11:10 - 11:30 |
| Diagnostics | Oral Presenation: Characterization of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) referred for transient elastography in a real-world canadian population | Paul Marrota | 307AB | vendredi 28 février 2025 | 11:30 - 11:40 |
| Public Health and Policy | Equity, diversity and inclusion in MASLD: the role of sex and ethnicity | Luca Valenti | 307AB | vendredi 28 février 2025 | 13:00 - 13:20 |
| Public Health and Policy | Lessons from the obesity epidemic | Michael Tsoukas | 307AB | vendredi 28 février 2025 | 13:20 - 13:40 |
| Public Health and Policy | Introducing multidisciplinary guidelines from Diabetes Canada and CanMASLD | Mohit Kehar & James Kim | 307AB | vendredi 28 février 2025 | 13:40 - 14:00 |
| Public Health and Policy | Oral Presentation: Significant decline in liver fibrosis screening among people living with diabetes in Ontario: a population-based study | Jessica Burnside | 307AB | vendredi 28 février 2025 | 14:00 - 14:10 |
| Therapeutics | Integrating behavioral interventions into a holistic approach to MASLD | Riccardo Righetti | 307AB | vendredi 28 février 2025 | 14:50 - 15:10 |
| Therapeutics | Incretin-based therapy for MASLD | Harpreet Bajaj | 307AB | vendredi 28 février 2025 | 15:10 - 15:30 |
| Therapeutics | MASH-targeted therapy for MASLD | Alnoor Ramji | 307AB | vendredi 28 février 2025 | 15:30 - 15:50 |
| Therapeutics | Oral Presentation: Impact of Bariatric Surgery on the Relationship Between Markers of Adiposity, Cardiometabolic Health, and Histologic Features of Metabolic DysfunctionAssociated Steatotic Liver Disease (MASLD) | Eve-Julie Tremblay | 307AB | vendredi 28 février 2025 | 15:50 - 16:00 |
| Closing | Closing remarks and future directions | Carla Coffin | 307AB | vendredi 28 février 2025 | 16:20 - 16:30 |
| Nom de session | Talk Title | Nom de la localisation | Date | Temps | |
|---|---|---|---|---|---|
| Clinical Symposium: How to Prevent and Manage adverse events during endoscopy | Frances Tse, Nauzer Forbes, Robert Bechara, Mark Borgaonkar, Charles Menard | 302AB | samedi 1 mars 2025 | 08:00 - 09:30 | |
| Clinical Symposium: CAG Best Clinical Papers | Frances Tse, Gregorios Leontiadis | 302AB | vendredi 28 février 2025 | 08:00 - 09:30 | |
| Clinical Symposium: Artificial Intelligence in GI | Peter Rossos, Daniel von Renteln, Samir Grover | 400C | samedi 1 mars 2025 | 08:00 - 09:30 | |
| Basic Science Symposium: Student Paper Prize Session | Premysl Bercik, Nathalie Perrault | 303AB | vendredi 28 février 2025 | 08:00 - 09:30 | |
| Post-Grad Course: Endoscopy Livestream and Onsite Lectures Part 1 | Robert Bechara, Yen-I Chen, Steven Heitman, Eric Lam, Jeff Mosko, Natalia Calo | 400C | vendredi 28 février 2025 | 08:00 - 09:30 | |
| Basic Science Symposium: Global IBD - host, environment and microbiome implications in IBD | Heather Armstrong, Deanna Gibson, Dermot McGovern, David Epstein, Turpin Williams | 303AB | samedi 1 mars 2025 | 08:00 - 09:30 | |
| Small Group Session: CF and GI Collide | Daniel Mulder, Michelle Ricci | 309A | dimanche 2 mars 2025 | 08:30 - 09:10 | |
| Small Group Session: Bloating | David Rodrigues | 304AB | dimanche 2 mars 2025 | 08:30 - 09:10 | |
| Small Group Session: GI Dismotility and Nutrition | Keith McIntosh and Adam Rahman | 308B | dimanche 2 mars 2025 | 08:30 - 09:10 | |
| Small Group Session: Multi-omic analysis and AI in basic research | Ken Lau, Carolina Tropini | 301B | dimanche 2 mars 2025 | 08:30 - 09:10 | |
| Small Group Session: Difficult Motility Cases Reviewed | Louis Liu, Christopher Andrews | 309A | dimanche 2 mars 2025 | 09:20 - 10:00 | |
| Small Group Session: Pouch Management | Jeff McCurdy | 308B | dimanche 2 mars 2025 | 09:20 - 10:00 | |
| Small Group Session: Exploring mechanisms underlying overlap between celiac disease and IBD: Food, microbiome or both?” | Jason Tye-Din | 301B | dimanche 2 mars 2025 | 09:20 - 10:00 | |
| Small Group Session: AI and Polyps | Daniel von RenteIn | 304AB | dimanche 2 mars 2025 | 09:20 - 10:00 | |
| Basic Science Symposium: Meet the Editors: The “bright” future of medical publishing | Paul Marrota | 303AB | vendredi 28 février 2025 | 10:00 - 11:30 | |
| Clinical Symposium: JCAG - From Local Impact to Global Health: Canadian Research Goes International | Eric Benchimol, Sama Anvari, Thomas Hoang, Thomas Krahn, Gilaad Kaplan | 302AB | vendredi 28 février 2025 | 10:00 - 11:30 | |
| Post-Grad Course: Endoscopy Livestream and Onsite Lectures Part 2 | Robert Bechara, Yen-I Chen, Steven Heitman, Eric Lam, Jeff Mosko, Natalia Calo | 400C | vendredi 28 février 2025 | 10:00 - 11:30 | |
| CDDW Hands-on Session - Physicians (must be registered) | Luca Valenti | 400B | vendredi 28 février 2025 | 10:00 - 11:30 | |
| CDDW Ultrasound Workshop 1 (must be registered) | Michael Tsoukas | 310 | vendredi 28 février 2025 | 10:00 - 11:30 | |
| CAG Award Lectures | Premysl Bercik, Geoff Nguyen, Neeraj Narula, Anne Griffiths, Desmond Leddin | 302AB | samedi 1 mars 2025 | 10:00 - 11:30 | |
| Joint Basic Science-Clinical Symposium on Celiac Disease | Elena Verdu, Donald Duerksen, Alberto Caminero, Jason Tye-Din, Sonia Kupfer, Jocelyn Sylvester | 400C | samedi 1 mars 2025 | 10:00 - 11:30 | |
| Clinical Symposium: Advances in Endoscopic Ultrasound - The Future is Bright | Yen-I Chen, Gary May, Eric Lam, Natalia Calo, Brian Yan, Amine Benmassaoud | 302AB | dimanche 2 mars 2025 | 10:30 - 12:00 | |
| Clinical Symposium: Food intolerances: is it the brain, the food or the gut? | Barbara Bielawska, Jennifer Jin, Wendy Busse, Sari Herman, Laurie Keefer | 400C | dimanche 2 mars 2025 | 10:30 - 12:00 | |
| Basic Science Symposium: Stem Cell Dynamics in Homeostasis and Disease | Tae-Hee Kim, Alex Gregorieff, Kelley Yan, Ken Lau, Arshad Ayyaz, Bo Li | 303AB | dimanche 2 mars 2025 | 10:30 - 12:00 | |
| CDDW Ultrasound Workshop 2 (must be registered) | Carla Nash and Elizabeth Squirell | 310 | vendredi 28 février 2025 | 13:00 - 14:30 | |
| CDDW Hands-on Session - Trainees (must be registered) | 400B | vendredi 28 février 2025 | 13:00 - 14:30 | ||
| NASPGHAN Clinical Symposium: Work better, Live better: Practical tips to incorporate AI in your work and defend yourself against burnout | Veronique Moranville, Eileen Crowley, Jennifer Lee, Karen Murray, Jason Silverman | 302AB | vendredi 28 février 2025 | 13:00 - 14:30 | |
| Post Grad Course on IBD | Reena Khanna, Jeff McCurdy, Anthony Otley, Jennifer Jones, Cynthia Seow | 400C | vendredi 28 février 2025 | 13:00 - 14:30 | |
| Basic Science Symposium: Pharmaco-microbiomics: Microbes vs. drugs and microbes as drugs | Deanna Gibson, Giada De Palma, Simon Hirota, Michelle Asbury, Alain Stintzi, Maggie Ma | 303AB | vendredi 28 février 2025 | 13:00 - 14:30 | |
| EDIRA Clinical Symposium: Voices and Visions: EDI Symposium on Indigenous Health | Alberto Caminero, Prévost Jantchou, Alexandra King, Brent Young, Juan-Nicolas Pena Sanchez | 302AB | vendredi 28 février 2025 | 15:00 - 16:30 | |
| Post-Grad Course: Functional GI Disease - A New Era of Motility Medications | Louis Liu, Adriana Lazarescu, David Rodrigues, Keith McIntosh, Matthew Miles | 400C | vendredi 28 février 2025 | 15:00 - 16:30 | |
| Basic Science Symposium: Minding our microbes: Microbiome-gut-brain interactions in health and disease | Giada De Palma, Samantha Gruenheid, Keith Sharkey, Rochellys Diaz Heijtz, Jessica Pei | 303AB | vendredi 28 février 2025 | 15:00 - 16:30 | |
| Small Group Session: Informed Consent: What Gastroenterologists Need to Know | Elisabeth Boileau | 308B | vendredi 28 février 2025 | 16:30 - 17:10 | |
| Small Group Session: Updates from SPOR IMAGINE: Implications for translational research | Paul Moayyedi | 301B | vendredi 28 février 2025 | 16:30 - 17:10 | |
| Small Group Session: Video Session: Name that lesion! | Paul Belletrutti | 309B | vendredi 28 février 2025 | 16:30 - 17:10 | |
| Small Group Session: When Less Is More: The Art and Science of De-prescribing in IBD | Elizabeth Squirell | 309A | vendredi 28 février 2025 | 16:30 - 17:10 | |
| Clinical Symposium: Preventative Care in IBD | Vivian Huang, Christopher Sheasgreen, Cynthia Seow, Eric Benchimol, Gilaad Kaplan | 302AB | samedi 1 mars 2025 | 16:30 - 18:00 | |
| Basic Science Symposium: Advances in mucosal immunology | Yasmin Nasser, Kirk Bergstrom, Brian Gulbransen, Arthur Mortha, Bruce Vallance, Irah King | 303AB | samedi 1 mars 2025 | 16:30 - 18:00 | |
| GIWomenCAN Fireside Chat: Navigating Leadership - Journeys, Challenges, and Mentoring the Next Generation | Laura Targownik, Catherine Dube, Jennifer Jones, Jill Tinmouth, Smita Halder, Nazia Selzner | 304AB | vendredi 28 février 2025 | 16:30 - 18:00 | |
| Small Group Session: Team Communication and Collaboration: Improving Psychological Safety and Situational Awareness | Elisabeth Boileau | 308B | vendredi 28 février 2025 | 17:20 - 18:00 | |
| Small Group Session: Gastroparesis or Dumping Syndrome | Premysl Bercik | 309B | vendredi 28 février 2025 | 17:20 - 18:00 | |
| Small Group Session: Recreating the human gut - Canadian organoid network | François Boudreau & Simon Hirota | 301B | vendredi 28 février 2025 | 17:20 - 18:00 | |
| CAG Opening & Awards Ceremony | Lawrence Hookey, Francois Boudreau, Charles Menard, Steven Gruchy, Frances Tse, Geoff Nguyen, Premysl Bercik | 400C | vendredi 28 février 2025 | 18:00 - 19:00 |
| Nom de session | Talk Title | Nom de la localisation | Date | Temps | |
|---|---|---|---|---|---|
| General Hepatology Abstracts I | Oral Abstract: MANAGEMENT OF ALCOHOL-RELATED HEPATITIS IN CANADA: A POPULATION-BASED STUDY EVALUATING THE IMPACT OF THE STOPAH TRIAL AND THE COVID-19 PANDEMIC | Bryce Tkachuk | 309B | samedi 1 mars 2025 | 08:00 - 08:15 |
| Public Health Policies and Interventions in Chronic Liver Disease | Characteristics of the blood donor population | Antoine Lewin | 307AB | samedi 1 mars 2025 | 08:00 - 08:15 |
| General Hepatology Abstracts II | Oral Abstract: THE OMEGA-3 DERIVATIVE, PROTECTIN DX, REDUCES HEPATIC BILE ACID LEVELS AND MITIGATES INFLAMMATION, ER STRESS AND FIBROSIS IN LIVER CELLS. | Audrey-Anne Lavoie | 309B | dimanche 2 mars 2025 | 08:00 - 08:15 |
| Basic Science / Translational Research 1 | Liver adrenoceptor alpha-1b plays a key role in energy and glucose homeostasis: impact of sex | Alex Caron | 306A | samedi 1 mars 2025 | 08:00 - 08:18 |
| General Hepatology Abstracts I | Oral Abstract: DERIVATION AND VALIDATION OF A RISK SCORE FOR POST-OPERATIVE MORTALITY IN PATIENTS WITH CIRRHOSIS | Edgar Medawar | 309B | samedi 1 mars 2025 | 08:15 - 08:30 |
| General Hepatology Abstracts II | Oral Abstract: MACROPHAGE HETEROGENEITY AND REDUCED INFLAMMATORY POTENTIAL IN HUMAN HEPATOCELLULAR CARCINOMA REVEALED BY SINGLE CELL AND SPATIAL TRANSCRIPTOMICS | Jawairia Atif | 309B | dimanche 2 mars 2025 | 08:15 - 08:30 |
| Public Health Policies and Interventions in Chronic Liver Disease | Hepatitis B blood donor testing | Steven Drews | 307AB | samedi 1 mars 2025 | 08:15 - 08:30 |
| Basic Science / Translational Research 1 | Immunological Landscape in Primary Sclerosing Cholangitis | Tallulah Andrews | 306A | samedi 1 mars 2025 | 08:18 - 08:36 |
| Public Health Policies and Interventions in Chronic Liver Disease | Epidemiologic trends in blood donor hepatitis B | Sheila O’Brien | 307AB | samedi 1 mars 2025 | 08:30 - 08:45 |
| General Hepatology Abstracts I | Oral Abstract: ALCOHOL USE DISORDER PHARMACOTHERAPY IN PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE: A SCOPING REVIEW | Louis Huynh | 309B | samedi 1 mars 2025 | 08:30 - 08:45 |
| General Hepatology Abstracts II | Oral Abstract: GLUCURONIDATION: THE LAST DEFENSIVE LINE AGAINST BILE ACID TOXICITY DURING CHOLESTASIS | Olivier Barbier | 309B | dimanche 2 mars 2025 | 08:30 - 08:45 |
| Basic Science / Translational Research 1 | The role of glutaredoxin-2 gene (Glrx2-/-) on the development of non-alcoholic fatty liver disease (NAFLD) in mice: Impact of sex. | Ryan Mailloux | 306A | samedi 1 mars 2025 | 08:36 - 08:54 |
| General Hepatology Abstracts I | Oral Abstract: HIGHER RATES OF LIVER-RELATED MORTALITY IN THOSE WITH CIRRHOSIS RESIDING IN THE MOST VULNERABLE NEIGHBOURHOODS FOR SOCIAL DETERMINANTS OF HEALTH: A CANADIAN POPULATION-BASED STUDY | Nawid Sayed | 309B | samedi 1 mars 2025 | 08:45 - 09:00 |
| Public Health Policies and Interventions in Chronic Liver Disease | Insight into blood donor hepatitis B through molecular testing | Emma Lee | 307AB | samedi 1 mars 2025 | 08:45 - 09:00 |
| General Hepatology Abstracts II | Oral Abstract: AMONGST AUTOIMMUNE LIVER DISEASES, PRIMARY SCLEROSING CHOLANGITIS DEMONSTRATES DISTINCT METHYLATION PROFILES ON CIRCULATING DNA | Soumita Ghosh | 309B | dimanche 2 mars 2025 | 08:45 - 09:00 |
| Basic Science / Translational Research 1 | AI tools applied to basic/translational science (including experimental modeling) | Mamatha Bhat | 306A | samedi 1 mars 2025 | 08:54 - 09:12 |
| General Hepatology Abstracts I | Oral Abstract: SIROLIMUS USE IN LIVER TRANSPLANTATION: ASSOCIATION WITH PROTEINURIA, RENAL DYSFUNCTION AND CARDIOVASCULAR DISEASE | Rojin Kaviani | 309B | samedi 1 mars 2025 | 09:00 - 09:15 |
| CAB Session - Respectful Indigenous Community Engaged Research: Perspectives and Learnings | Kate Dunn, Victoria Thomas, Jessy Dame, Renee Masching, Andrew Mendlowitz | 306A | dimanche 2 mars 2025 | 09:00 - 10:00 | |
| Basic Science / Translational Research 1 | Leveraging serum ammonia in the approach to acute liver failure | Filipe Cardoso | 306A | samedi 1 mars 2025 | 09:12 - 09:30 |
| Cirrhosis | Recompensation in Cirrhosis: Practical Tips | Juan Abraldes | 307AB | dimanche 2 mars 2025 | 10:30 - 10:55 |
| Viral Hepatitis - Updates on Hep B and D | WHO Guidelines: What's New and Different? | Jordan Feld | 309B | dimanche 2 mars 2025 | 10:30 - 10:55 |
| Liver Transplantation | Remote Screening for Transplant Candidates | Binu V. John | 306A | dimanche 2 mars 2025 | 10:30 - 10:55 |
| Cirrhosis | Pregnancy and liver disease | Saumya Jayakumar | 307AB | dimanche 2 mars 2025 | 10:55 - 11:20 |
| Viral Hepatitis - Updates on Hep B and D | Screening for HDV: Who and How? | Emma Lee | 309B | dimanche 2 mars 2025 | 10:55 - 11:20 |
| Liver Transplantation | DEI in Transplant | Cynthia Tsien | 306A | dimanche 2 mars 2025 | 10:55 - 11:20 |
| Liver Transplantation | Liver related liver transplant (outcomes and insight) | Nazia Selzner | 306A | dimanche 2 mars 2025 | 11:20 - 11:45 |
| Cirrhosis | The role of Palliative care including MAID in Patients with Cirrhosis | Grace Warmel | 307AB | dimanche 2 mars 2025 | 11:20 - 11:45 |
| Viral Hepatitis - Updates on Hep B and D | New Treatments for HDV | Curtis Cooper | 309B | dimanche 2 mars 2025 | 11:20 - 11:45 |
| Avancées récentes en hépatologie : MASLD, hépatites virales et autres maladies du foie | Maladie hépatique associée à une dysfonction métabolique (MASLD) | Anne-Marie Carreau | 306A | samedi 1 mars 2025 | 13:00 - 13:20 |
| Avancées récentes en hépatologie : MASLD, hépatites virales et autres maladies du foie | Hépatite virale et cirrhose | Amine Mohamed Benmassaoud | 306A | samedi 1 mars 2025 | 13:20 - 13:40 |
| Avancées récentes en hépatologie : MASLD, hépatites virales et autres maladies du foie | Maladies hépatiques auto-immunes et cholestatiques | Julian Hercun | 306A | samedi 1 mars 2025 | 13:40 - 14:00 |
| Alcohol-Associated Liver Disease: Screening, Integration and Treatment | Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients with ALD across Canada | Noreen Singh | 307AB | samedi 1 mars 2025 | 15:00 - 15:25 |
| Pediatric Hepatology | Surgical management of portal vein obstruction | Caroline Lemoine | 309B | samedi 1 mars 2025 | 15:00 - 15:25 |
| MASLD/MASH | Obesity management in Chronic Liver Disease | Ellina Lytvyak | 306A | samedi 1 mars 2025 | 15:00 - 15:25 |
| MASLD/MASH | Lean MASLD | Keyur Patel | 306A | samedi 1 mars 2025 | 15:25 - 15:50 |
| Alcohol-Associated Liver Disease: Screening, Integration and Treatment | Alcohol Use Disorder in Cirrhosis: An Alberta Potpourri | Monty Ghosh | 307AB | samedi 1 mars 2025 | 15:25 - 15:50 |
| Pediatric Hepatology | Anticoagulation in liver disease / PV thrombus | Kerry Wong | 309B | samedi 1 mars 2025 | 15:25 - 15:50 |
| Pediatric Hepatology | Interventional Radiology in PV obstruction | Stephen Ho | 309B | samedi 1 mars 2025 | 15:50 - 16:15 |
| Alcohol-Associated Liver Disease: Screening, Integration and Treatment | Building multidisciplinary clinics for management of ALD: from process to evaluation | Nabiha Faisal | 307AB | samedi 1 mars 2025 | 15:50 - 16:15 |
| MASLD/MASH | Medications for MASH | Luca Valenti | 306A | samedi 1 mars 2025 | 15:50 - 16:15 |
| Hepatobiliary Malignancies | Systemic treatments for Macrovascular invasion | Arndt Vogel | 307AB | samedi 1 mars 2025 | 16:30 - 16:55 |
| Immune-Mediated and Cholestatic Liver Diseases | First/second line treatment for autoimmune hepatitis | Julian Hercun | 306A | samedi 1 mars 2025 | 16:30 - 16:55 |
| Sass-Kortsak Award Lecture | New therapies for cholestasis and the effect on natural history | Deirdre Kelly | 309B | samedi 1 mars 2025 | 16:30 - 17:00 |
| Hepatobiliary Malignancies | Liver Transplant for Macrovascular invasion | David Henault | 307AB | samedi 1 mars 2025 | 16:55 - 17:20 |
| Immune-Mediated and Cholestatic Liver Diseases | Management of pruritus in chronic cholestatisis | Aldo Montano-Loza | 306A | samedi 1 mars 2025 | 16:55 - 17:20 |
| Opening Ceremony | Opening Greetings, Land Acknowledgment, Ceremony | Carla Coffin and Giada Sebastiani | 306A | vendredi 28 février 2025 | 17:10 - 17:25 |
| Immune-Mediated and Cholestatic Liver Diseases | Second line therapy in PBC in 2025 | Gideon Hirschfield | 306A | samedi 1 mars 2025 | 17:20 - 17:45 |
| Hepatobiliary Malignancies | Radioembolization in Macrovascular invasion | Riad Salem | 307AB | samedi 1 mars 2025 | 17:20 - 17:45 |
| Awards Ceremony | Carla Coffin and Giada Sebastiani | 306A | vendredi 28 février 2025 | 17:25 - 17:40 | |
| CLF-CLM Gold Medal Lecture | Award Presentation, Receipient Lecture | Carla Coffin,Chris Rose, Mark Swain | 306A | vendredi 28 février 2025 | 17:40 - 18:25 |
| Nom de session | Talk Title | Nom de la localisation | Date | Temps | |
|---|---|---|---|---|---|
| Joint CDDW-CLM Symposium: Year in Review - Top GI and Hep Papers of 2024 | Top Hepatology Papers | Mark Swain | 303AB | samedi 1 mars 2025 | 10:00 - 11:30 |
| Joint CDDW-CLM Symposium: Year in Review - Top GI and Hep Papers of 2024 | Top Gastroenterology Papers | Paul Moayyedi | 303AB | samedi 1 mars 2025 | 10:00 - 11:30 |
| Joint CDDW-CLM Symposium: Microbiota in GI and liver diseases: Ready for prime time? | Premysl Bercik, Chris Rose, Mike Surette, Jasmohan Bajaj, Kenneth Croitoru, Geoffrey Preidis | 400C | samedi 1 mars 2025 | 13:00 - 14:30 | |
| McKenna Memorial Lecture (CAGF and Distinguished Service Awards) | Lawrence Hookey, Stephen Vanner | 400C | samedi 1 mars 2025 | 15:00 - 16:30 | |
| Joint CDDW-CLM Symposium: Cage MatchesCAG: Colon Cancer Screening - What is the Optimal Age WindowCASL: Medical vs Interventional Management of Obesity in Patients with Chronic Disease | CLM: Debate: Medical vs. Interventional Management of Obesity in Patients with Chronic Liver Disease | Lawrence Hookey, Carla Coffin, Qasim Khan, Giada Sebastiani, Jill Tinmouth, Jennifer Tellford | 400C | samedi 1 mars 2025 | 16:30 - 18:00 |
| 07:30 - 08:00 | CanHepC Opening Registration, breakfast - Inscription, petit déjeuner Edith Picard 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:00 - 08:15 | CanHepC Opening Elder’s blessing, Welcome and Introductions Marie-Louise Vachon and Guillaume Fontaine 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:00 - 09:30 | CDDW Clinical Symposium: CAG Best Clinical Papers Frances Tse, Gregorios Leontiadis 302AB | CDDW Post-Grad Course: Endoscopy Livestream and Onsite Lectures Part 1 Robert Bechara, Yen-I Chen, Steven Heitman, Eric Lam, Jeff Mosko, Natalia Calo 400C | CDDW Basic Science Symposium: Student Paper Prize Session Premysl Bercik, Nathalie Perrault 303AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:15 - 08:45 | CanHepC Biomedical Research Challenges in HCV vaccine design - can our models give us insights? Thomas Pietschmann 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:30 - 08:40 | CanMASLD Opening Opening Remarks Giada Sebastiani 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:40 - 09:00 | CanMASLD Epidemiology and Natural History Epidemiology and knowledge gaps in Canada: where do we stand? Sahar Saeed 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:45 - 09:15 | CanHepC Biomedical Research Molecular mechanisms of development of T-cell exhaustion during chronic viral infection in the context of HCV Mohamed Abdel Hakeem 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:00 - 09:20 | CanMASLD Epidemiology and Natural History The relationship among obesity, diabetes and adipose tissue: implication for MASLD Andre Tchernof 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:15 - 09:30 | CanHepC Biomedical Research Oral Presentations: Investigating the role of protein kinase r in the antiviral activity of cyclosporine a against HCV Carla Gallardo 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:20 - 09:40 | CanMASLD Epidemiology and Natural History Don’t forget the heart! Cardiovascular implications in MASLD Paolo Raggi 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:30 - 09:45 | CanHepC Biomedical Research Oral Presentations: HCV-specific CD4+ T-cells are targeted by HIV-1 infection and viral reservoir persistence during antiretroviral therapy Samaa T. Gobran 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:40 - 10:10 | CanMASLD Epidemiology and Natural History Oral Presentation: Characteristics and burden of illness of persons with metabolic dysfunction-associated steatotic liver disease (MASLD) in Ontario, Canada: an observational study Keyur Patel 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:45 - 10:05 | CanHepC Coffee Break - Pause café and poster viewing 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:00 - 11:30 | CDDW CDDW Hands-on Session - Physicians (must be registered) Luca Valenti 400B | CDDW Basic Science Symposium: Meet the Editors: The “bright” future of medical publishing Paul Marrota 303AB | CDDW Clinical Symposium: JCAG - From Local Impact to Global Health: Canadian Research Goes International Eric Benchimol, Sama Anvari, Thomas Hoang, Thomas Krahn, Gilaad Kaplan 302AB | CDDW Post-Grad Course: Endoscopy Livestream and Onsite Lectures Part 2 Robert Bechara, Yen-I Chen, Steven Heitman, Eric Lam, Jeff Mosko, Natalia Calo 400C | CDDW CDDW Ultrasound Workshop 1 (must be registered) Michael Tsoukas 310 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:05 - 10:35 | CanHepC Clinical Research Developing and implementing strategies for HCV point-of-care testing adoption in the United States Guillaume Fontaine 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:30 - 10:50 | CanMASLD Diagnostics Non-invasive tests for risk stratification Keyur Patel 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:30 - 12:00 | CanMASLD Diagnostics Diagnostics Magnus McLeod & Felice Cinque 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:35 - 11:05 | CanHepC Clinical Research Linkage to HCV care for pregnant and postpartum women Mia Biondi 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:50 - 11:10 | CanMASLD Diagnostics Imaging assessment of MASLD and artificial intelligence applications Jérémy Dana 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:05 - 11:20 | CanHepC Clinical Research Oral Presentations: Real-world implementation of point-of-care (POC) HCV RNA testing in a mobile unit in homeless encampments and shelters in Ontario, Canada: Impact on the Cascade of Care Lindsay Myles 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:10 - 11:30 | CanMASLD Diagnostics Models of care for MASLD Abdel Aziz Shaheen 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:20 - 11:35 | CanHepC Clinical Research Oral Presentations: Hepatitis C self-testing among people with experience in Canadian corrections Tamara Barnett 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:30 - 11:40 | CanMASLD Diagnostics Oral Presenation: Characterization of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) referred for transient elastography in a real-world canadian population Paul Marrota 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12:30 - 13:00 | CanHepC Poster Session – Présentation des Affiches : CanHepC evaluation of posters 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:00 - 13:20 | CanMASLD Public Health and Policy Equity, diversity and inclusion in MASLD: the role of sex and ethnicity Luca Valenti 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:00 - 13:55 | CanHepC Panel Addressing Disparities Impacting Women: Prioritizing Gender-Responsive Strategies in the Hepatitis C Response Madison Kennedy, Mia Biondi, Valérie Martel-Lafferière, Lucie-Catherine Ouimet, Danielle Willier, Michella Seymour, Victoria Thomas 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:00 - 14:30 | CDDW CDDW Ultrasound Workshop 2 (must be registered) Carla Nash and Elizabeth Squirell 310 | CDDW CDDW Hands-on Session - Trainees (must be registered) 400B | CDDW NASPGHAN Clinical Symposium: Work better, Live better: Practical tips to incorporate AI in your work and defend yourself against burnout Veronique Moranville, Eileen Crowley, Jennifer Lee, Karen Murray, Jason Silverman 302AB | CDDW Basic Science Symposium: Pharmaco-microbiomics: Microbes vs. drugs and microbes as drugs Deanna Gibson, Giada De Palma, Simon Hirota, Michelle Asbury, Alain Stintzi, Maggie Ma 303AB | CDDW Post Grad Course on IBD Reena Khanna, Jeff McCurdy, Anthony Otley, Jennifer Jones, Cynthia Seow 400C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:20 - 13:40 | CanMASLD Public Health and Policy Lessons from the obesity epidemic Michael Tsoukas 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:40 - 14:00 | CanMASLD Public Health and Policy Introducing multidisciplinary guidelines from Diabetes Canada and CanMASLD Mohit Kehar & James Kim 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:55 - 14:25 | CanHepC Population Health and Health Services Research Evaluating varying strategies to address disparities in HCV care access and uptake Seun O Falade-Nwulia 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14:00 - 14:10 | CanMASLD Public Health and Policy Oral Presentation: Significant decline in liver fibrosis screening among people living with diabetes in Ontario: a population-based study Jessica Burnside 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14:25 - 14:45 | CanHepC Population Health and Health Services Research Strengthening evidence-support systems to inform policy decision-making Mike Wilson 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14:45 - 15:05 | CanHepC Coffee Break - Pause café and poster browsing 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14:50 - 15:10 | CanMASLD Therapeutics Integrating behavioral interventions into a holistic approach to MASLD Riccardo Righetti 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:00 - 16:30 | CDDW Basic Science Symposium: Minding our microbes: Microbiome-gut-brain interactions in health and disease Giada De Palma, Samantha Gruenheid, Keith Sharkey, Rochellys Diaz Heijtz, Jessica Pei 303AB | CDDW EDIRA Clinical Symposium: Voices and Visions: EDI Symposium on Indigenous Health Alberto Caminero, Prévost Jantchou, Alexandra King, Brent Young, Juan-Nicolas Pena Sanchez 302AB | CDDW Post-Grad Course: Functional GI Disease - A New Era of Motility Medications Louis Liu, Adriana Lazarescu, David Rodrigues, Keith McIntosh, Matthew Miles 400C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:05 - 15:35 | CanHepC Population Health and Health Services Research Sex and gender differences in HCV risk, prevention and cascade of care Sarah Larney 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:10 - 15:30 | CanMASLD Therapeutics Incretin-based therapy for MASLD Harpreet Bajaj 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:30 - 15:50 | CanMASLD Therapeutics MASH-targeted therapy for MASLD Alnoor Ramji 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:35 - 15:50 | CanHepC Population Health and Health Services Research Oral Presentation: Barriers and facilitators to improving uptake of the prison needle exchange program in Canadian federal prisons: Lessons learned using nominal group technique Andrew B. Mendolwitz 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:50 - 16:00 | CanMASLD Therapeutics Oral Presentation: Impact of Bariatric Surgery on the Relationship Between Markers of Adiposity, Cardiometabolic Health, and Histologic Features of Metabolic DysfunctionAssociated Steatotic Liver Disease (MASLD) Eve-Julie Tremblay 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:50 - 16:05 | CanHepC Population Health and Health Services Research Oral Presentation: Disparities in hepatocellular carcinoma screening and in its detection rates in individuals with Hepatitis C or C and cirrhosis in Canada Gisela MacPhail 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:05 - 16:20 | CanHepC Population Health and Health Services Research Oral Presentation: Evaluation of Hepatitis C Virus testing and care for infants born to individuals positive before or during pregnancy in Ontario, Canada: A Population-based retrospective analysis Jean Damascene Makuza 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:20 - 16:30 | CanMASLD Closing Closing remarks and future directions Carla Coffin 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:20 - 16:35 | CanHepC Population Health and Health Services Research Oral Presentation: Simple but Not Easy: Scaffolding the HCV Cascade of Care Nadine Kronfli 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:30 - 17:10 | CDDW Small Group Session: When Less Is More: The Art and Science of De-prescribing in IBD Elizabeth Squirell 309A | CDDW Small Group Session: Video Session: Name that lesion! Paul Belletrutti 309B | CDDW Small Group Session: Updates from SPOR IMAGINE: Implications for translational research Paul Moayyedi 301B | CDDW Small Group Session: Informed Consent: What Gastroenterologists Need to Know Elisabeth Boileau 308B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:30 - 18:00 | CDDW GIWomenCAN Fireside Chat: Navigating Leadership - Journeys, Challenges, and Mentoring the Next Generation Laura Targownik, Catherine Dube, Jennifer Jones, Jill Tinmouth, Smita Halder, Nazia Selzner
304AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:35 - 16:45 | CanHepC Closing CanHepC Trainee Awards Ceremony Nadine Kronfli 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:45 - 16:55 | CanHepC Closing Remarks - Mot de la fin Marie-Louise Vachon and Guillaume Fontaine 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17:10 - 17:25 | CLM Opening Ceremony Opening Greetings, Land Acknowledgment, Ceremony Carla Coffin and Giada Sebastiani 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17:20 - 18:00 | CDDW Small Group Session: Team Communication and Collaboration: Improving Psychological Safety and Situational Awareness Elisabeth Boileau 308B | CDDW Small Group Session: Recreating the human gut - Canadian organoid network François Boudreau & Simon Hirota 301B | CDDW Small Group Session: Gastroparesis or Dumping Syndrome Premysl Bercik 309B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17:25 - 17:40 | CLM Awards Ceremony Carla Coffin and Giada Sebastiani 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17:40 - 18:25 | CLM CLF-CLM Gold Medal Lecture Award Presentation, Receipient Lecture Carla Coffin,Chris Rose, Mark Swain 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18:00 - 19:00 | CDDW CAG Opening & Awards Ceremony Lawrence Hookey, Francois Boudreau, Charles Menard, Steven Gruchy, Frances Tse, Geoff Nguyen, Premysl Bercik 400C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:00 - 08:15 | CLM General Hepatology Abstracts I Oral Abstract: MANAGEMENT OF ALCOHOL-RELATED HEPATITIS IN CANADA: A POPULATION-BASED STUDY EVALUATING THE IMPACT OF THE STOPAH TRIAL AND THE COVID-19 PANDEMIC Bryce Tkachuk 309B | CLM Public Health Policies and Interventions in Chronic Liver Disease Characteristics of the blood donor population Antoine Lewin 307AB | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:00 - 08:18 | CLM Basic Science / Translational Research 1 Liver adrenoceptor alpha-1b plays a key role in energy and glucose homeostasis: impact of sex Alex Caron 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:00 - 09:30 | CDDW Basic Science Symposium: Global IBD - host, environment and microbiome implications in IBD Heather Armstrong, Deanna Gibson, Dermot McGovern, David Epstein, Turpin Williams 303AB | CDDW Clinical Symposium: Artificial Intelligence in GI Peter Rossos, Daniel von Renteln, Samir Grover 400C | CDDW Clinical Symposium: How to Prevent and Manage adverse events during endoscopy Frances Tse, Nauzer Forbes, Robert Bechara, Mark Borgaonkar, Charles Menard 302AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:15 - 08:30 | CLM Public Health Policies and Interventions in Chronic Liver Disease Hepatitis B blood donor testing Steven Drews 307AB | CLM General Hepatology Abstracts I Oral Abstract: DERIVATION AND VALIDATION OF A RISK SCORE FOR POST-OPERATIVE MORTALITY IN PATIENTS WITH CIRRHOSIS Edgar Medawar 309B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:18 - 08:36 | CLM Basic Science / Translational Research 1 Immunological Landscape in Primary Sclerosing Cholangitis Tallulah Andrews 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:30 - 08:45 | CLM Public Health Policies and Interventions in Chronic Liver Disease Epidemiologic trends in blood donor hepatitis B Sheila O’Brien 307AB | CLM General Hepatology Abstracts I Oral Abstract: ALCOHOL USE DISORDER PHARMACOTHERAPY IN PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE: A SCOPING REVIEW Louis Huynh 309B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:30 - 09:15 | CAHN MASLD/MASH – management and future of therapeutics MASLD/MASH – management and future of therapeutics Giada Sebastiani 308A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:36 - 08:54 | CLM Basic Science / Translational Research 1 The role of glutaredoxin-2 gene (Glrx2-/-) on the development of non-alcoholic fatty liver disease (NAFLD) in mice: Impact of sex. Ryan Mailloux 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:45 - 09:00 | CLM Public Health Policies and Interventions in Chronic Liver Disease Insight into blood donor hepatitis B through molecular testing Emma Lee 307AB | CLM General Hepatology Abstracts I Oral Abstract: HIGHER RATES OF LIVER-RELATED MORTALITY IN THOSE WITH CIRRHOSIS RESIDING IN THE MOST VULNERABLE NEIGHBOURHOODS FOR SOCIAL DETERMINANTS OF HEALTH: A CANADIAN POPULATION-BASED STUDY Nawid Sayed 309B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:54 - 09:12 | CLM Basic Science / Translational Research 1 AI tools applied to basic/translational science (including experimental modeling) Mamatha Bhat 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:00 - 09:15 | CLM General Hepatology Abstracts I Oral Abstract: SIROLIMUS USE IN LIVER TRANSPLANTATION: ASSOCIATION WITH PROTEINURIA, RENAL DYSFUNCTION AND CARDIOVASCULAR DISEASE Rojin Kaviani 309B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:12 - 09:30 | CLM Basic Science / Translational Research 1 Leveraging serum ammonia in the approach to acute liver failure Filipe Cardoso 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:00 - 10:30 | CAHN Nurse-led Models of Care in Hepatology Nurse-led hepatology program Hayley McPhail and Carmen Cabral 308A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:00 - 11:30 | Joint CDDW-CLM Joint CDDW-CLM Symposium: Year in Review - Top GI and Hep Papers of 2024 Top Gastroenterology Papers Paul Moayyedi 303AB | CDDW Joint Basic Science-Clinical Symposium on Celiac Disease Elena Verdu, Donald Duerksen, Alberto Caminero, Jason Tye-Din, Sonia Kupfer, Jocelyn Sylvester 400C | CDDW CAG Award Lectures Premysl Bercik, Geoff Nguyen, Neeraj Narula, Anne Griffiths, Desmond Leddin 302AB | Joint CDDW-CLM Joint CDDW-CLM Symposium: Year in Review - Top GI and Hep Papers of 2024 Top Hepatology Papers Mark Swain 303AB | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:30 - 11:00 | CAHN Nurse-led Models of Care in Hepatology Nurse-led program in North Bay Saskia Hildebrandt, Keri McGuire-Trahan, and Kaitlyn Barber 308A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:15 - 11:45 | CAHN Navigating Liver Health During and After Pregnancy HCV and post-pregnancy Chelsea Elwood 308A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:45 - 12:15 | CAHN Navigating Liver Health During and After Pregnancy Pregnancy and liver disease Hin Hin Ko 308A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:00 - 13:20 | CLM Avancées récentes en hépatologie : MASLD, hépatites virales et autres maladies du foie Maladie hépatique associée à une dysfonction métabolique (MASLD) Anne-Marie Carreau 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:00 - 14:30 | Joint CDDW-CLM Joint CDDW-CLM Symposium: Microbiota in GI and liver diseases: Ready for prime time? Premysl Bercik, Chris Rose, Mike Surette, Jasmohan Bajaj, Kenneth Croitoru, Geoffrey Preidis 400C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:20 - 13:40 | CLM Avancées récentes en hépatologie : MASLD, hépatites virales et autres maladies du foie Hépatite virale et cirrhose Amine Mohamed Benmassaoud 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13:40 - 14:00 | CLM Avancées récentes en hépatologie : MASLD, hépatites virales et autres maladies du foie Maladies hépatiques auto-immunes et cholestatiques Julian Hercun 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:00 - 15:25 | CLM MASLD/MASH Obesity management in Chronic Liver Disease Ellina Lytvyak 306A | CLM Pediatric Hepatology Surgical management of portal vein obstruction Caroline Lemoine 309B | CLM Alcohol-Associated Liver Disease: Screening, Integration and Treatment Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients with ALD across Canada Noreen Singh 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:00 - 16:30 | Joint CDDW-CLM McKenna Memorial Lecture (CAGF and Distinguished Service Awards) Lawrence Hookey, Stephen Vanner 400C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:25 - 15:50 | CLM Pediatric Hepatology Anticoagulation in liver disease / PV thrombus Kerry Wong 309B | CLM MASLD/MASH Lean MASLD Keyur Patel 306A | CLM Alcohol-Associated Liver Disease: Screening, Integration and Treatment Alcohol Use Disorder in Cirrhosis: An Alberta Potpourri Monty Ghosh 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15:50 - 16:15 | CLM Pediatric Hepatology Interventional Radiology in PV obstruction Stephen Ho 309B | CLM Alcohol-Associated Liver Disease: Screening, Integration and Treatment Building multidisciplinary clinics for management of ALD: from process to evaluation Nabiha Faisal 307AB | CLM MASLD/MASH Medications for MASH Luca Valenti 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:30 - 16:55 | CLM Hepatobiliary Malignancies Systemic treatments for Macrovascular invasion Arndt Vogel 307AB | CLM Immune-Mediated and Cholestatic Liver Diseases First/second line treatment for autoimmune hepatitis Julian Hercun 306A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:30 - 17:00 | CLM Sass-Kortsak Award Lecture New therapies for cholestasis and the effect on natural history Deirdre Kelly 309B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:30 - 18:00 | CDDW Basic Science Symposium: Advances in mucosal immunology Yasmin Nasser, Kirk Bergstrom, Brian Gulbransen, Arthur Mortha, Bruce Vallance, Irah King 303AB | CDDW Clinical Symposium: Preventative Care in IBD Vivian Huang, Christopher Sheasgreen, Cynthia Seow, Eric Benchimol, Gilaad Kaplan 302AB | Joint CDDW-CLM Joint CDDW-CLM Symposium: Cage MatchesCAG: Colon Cancer Screening - What is the Optimal Age WindowCASL: Medical vs Interventional Management of Obesity in Patients with Chronic Disease CLM: Debate: Medical vs. Interventional Management of Obesity in Patients with Chronic Liver Disease Lawrence Hookey, Carla Coffin, Qasim Khan, Giada Sebastiani, Jill Tinmouth, Jennifer Tellford 400C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16:55 - 17:20 | CLM Immune-Mediated and Cholestatic Liver Diseases Management of pruritus in chronic cholestatisis Aldo Montano-Loza 306A | CLM Hepatobiliary Malignancies Liver Transplant for Macrovascular invasion David Henault 307AB | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17:20 - 17:45 | CLM Immune-Mediated and Cholestatic Liver Diseases Second line therapy in PBC in 2025 Gideon Hirschfield 306A | CLM Hepatobiliary Malignancies Radioembolization in Macrovascular invasion Riad Salem 307AB | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:00 - 08:15 | CLM General Hepatology Abstracts II Oral Abstract: THE OMEGA-3 DERIVATIVE, PROTECTIN DX, REDUCES HEPATIC BILE ACID LEVELS AND MITIGATES INFLAMMATION, ER STRESS AND FIBROSIS IN LIVER CELLS. Audrey-Anne Lavoie 309B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:15 - 08:30 | CLM General Hepatology Abstracts II Oral Abstract: MACROPHAGE HETEROGENEITY AND REDUCED INFLAMMATORY POTENTIAL IN HUMAN HEPATOCELLULAR CARCINOMA REVEALED BY SINGLE CELL AND SPATIAL TRANSCRIPTOMICS Jawairia Atif 309B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:30 - 08:45 | CLM General Hepatology Abstracts II Oral Abstract: GLUCURONIDATION: THE LAST DEFENSIVE LINE AGAINST BILE ACID TOXICITY DURING CHOLESTASIS Olivier Barbier 309B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:30 - 09:10 | CDDW Small Group Session: CF and GI Collide Daniel Mulder, Michelle Ricci 309A | CDDW Small Group Session: Bloating David Rodrigues 304AB | CDDW Small Group Session: Multi-omic analysis and AI in basic research Ken Lau, Carolina Tropini 301B | CDDW Small Group Session: GI Dismotility and Nutrition Keith McIntosh and Adam Rahman 308B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 08:45 - 09:00 | CLM General Hepatology Abstracts II Oral Abstract: AMONGST AUTOIMMUNE LIVER DISEASES, PRIMARY SCLEROSING CHOLANGITIS DEMONSTRATES DISTINCT METHYLATION PROFILES ON CIRCULATING DNA Soumita Ghosh 309B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:00 - 10:00 | CLM CAB Session - Respectful Indigenous Community Engaged Research: Perspectives and Learnings Kate Dunn, Victoria Thomas, Jessy Dame, Renee Masching, Andrew Mendlowitz 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09:20 - 10:00 | CDDW Small Group Session: Exploring mechanisms underlying overlap between celiac disease and IBD: Food, microbiome or both?” Jason Tye-Din 301B | CDDW Small Group Session: Pouch Management Jeff McCurdy 308B | CDDW Small Group Session: AI and Polyps Daniel von RenteIn 304AB | CDDW Small Group Session: Difficult Motility Cases Reviewed Louis Liu, Christopher Andrews 309A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:30 - 10:55 | CLM Viral Hepatitis - Updates on Hep B and D WHO Guidelines: What's New and Different? Jordan Feld 309B | CLM Liver Transplantation Remote Screening for Transplant Candidates Binu V. John 306A | CLM Cirrhosis Recompensation in Cirrhosis: Practical Tips Juan Abraldes 307AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:30 - 12:00 | CDDW Clinical Symposium: Advances in Endoscopic Ultrasound - The Future is Bright Yen-I Chen, Gary May, Eric Lam, Natalia Calo, Brian Yan, Amine Benmassaoud 302AB | CDDW Clinical Symposium: Food intolerances: is it the brain, the food or the gut? Barbara Bielawska, Jennifer Jin, Wendy Busse, Sari Herman, Laurie Keefer 400C | CDDW Basic Science Symposium: Stem Cell Dynamics in Homeostasis and Disease Tae-Hee Kim, Alex Gregorieff, Kelley Yan, Ken Lau, Arshad Ayyaz, Bo Li 303AB | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:55 - 11:20 | CLM Liver Transplantation DEI in Transplant Cynthia Tsien 306A | CLM Cirrhosis Pregnancy and liver disease Saumya Jayakumar 307AB | CLM Viral Hepatitis - Updates on Hep B and D Screening for HDV: Who and How? Emma Lee 309B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:20 - 11:45 | CLM Cirrhosis The role of Palliative care including MAID in Patients with Cirrhosis Grace Warmel 307AB | CLM Viral Hepatitis - Updates on Hep B and D New Treatments for HDV Curtis Cooper 309B | CLM Liver Transplantation Liver related liver transplant (outcomes and insight) Nazia Selzner 306A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
